רנקסה 1000 מ"ג

Maa: Israel

Kieli: heprea

Lähde: Ministry of Health

Aktiivinen ainesosa:

RANOLAZINE 1000 MG

Saatavilla:

NEOPHARM LTD

ATC-koodi:

C01EB18

Lääkemuoto:

TABLETS EXTENDED RELEASE

Antoreitti:

PER OS

Valmistaja:

CV THERAPEUTICS INC, USA

Terapeuttinen ryhmä:

RANOLAZINE

Käyttöaiheet:

Ranexa is indicated for the treatment of chronic angina. Ranexa is also indicated as add-on therapy for the symptomati treatment of patients with chronic angina who are inadequately controlled or intolerant to other first-line antianginal therapies (such as beta-blockers and/or calcium antagonists).Ranexa may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ACE inhibitors, and angiotensin receptor blockers.

Valtuutus päivämäärä:

2010-10-01